Cardiovascular pharmacology of SCH 59761, a highly potent, non-selective, adenosine receptor agonist

Drug Development Research

Volumn 39, Issue 1, 1996, Pages 1-11

  Casati, Carlo ^a   Lozza, Gianluca ^a   Conti, Annamaria ^a   Ongini, Ennio ^a   Monopoli, Angela ^a  

^a Schering Plough Research Institute   (Italy)

Author keywords

A(2A) adenosine receptors; A1 adenosine receptors; Adenosine receptor agonist; Cardiovascular pharmacology; SCH 59761

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; CREATINE KINASE; CYCLOHEXYLADENOSINE; RECEPTOR SUBTYPE; SCH 59761; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; BRAIN CORTEX; CATTLE; CELL MEMBRANE; CORONARY ARTERY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; HEART; HEART ATRIUM; HYPERTENSION; IN VITRO STUDY; INOTROPISM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TACHYCARDIA; THROMBOCYTE; THROMBOCYTE AGGREGATION; VASODILATATION;

EID: 0030497902     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(19960901)39:1<1::AID-DDR1>3.0.CO;2-J     Document Type: Article

References (39)

1. 2 receptors. Eur J Pharmacol 196:69-76.
2. 2a adenosine agonists. Hypertension 25:564-569.
3. Brockway BP, Mills PA, Azar SH (1991): A new method for continuous chronic measurement recording of blood pressure, heart rate activity in the rat via radio-telemetry. Clin Exp Hypertens 13:885-895.
4. 3H]phenylxanthine. Proc Natl Acad Sei USA 77: 5547-5551.
5. Camm AJ, Garrat CJ (1991): Adenosine supraventricular tachycardia. N Engl J Med 325:1621-1629.
6. Casati C, Monopoli A, Forlani A, Bonizzoni E, Ongini E (1995): Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats. J Pharmacol Exp Ther 275:914-919.
7. 2-selective adenosine agonist, C6521680. J Chromatography 578:77-83.
8. 2 adenosine receptor activation inhibits and stimulates renin secretion of rat renal cortical slices. J Pharmacol Exp Ther 232:589-594.
9. Coates J, Gurden MF, Harris C, Kennedy I, Sheehan MJ, Strong P (1994): Adenosine receptor classification: Quo vadimus? Nucleosides Nucleotides 13:1953-1976.
10. Dionisotti S, Zocchi C, Varani K, Borea PA, Ongini E (1992): Effects of adenosine derivatives on human rabbit platelet aggregation. Naunyn-Schmiedebergs Arch Pharmacol 346:673-676.
11. 3H]SCH 58261. J Pharmacol Exp Ther 278:1209-1214.
12. Downey JM, Cohen MV (1995): Role of adenosine in the phenomenon of preconditioning. In Belardinelli L, Pelleg R (eds): Aden-osine Adenine Nucleotides: From Molecular Biology to Physiology. Boston: Kluwer Academic Publishers, pp 461-478.
13. Draper NR, Smith M (1981): Applied Regression Analysis. New York: John Wiley & Sons, pp 482-499.
14. Finney DJ (1978): Statistical Methods in Biological Assays. London: Griffin, pp 69-99.
15. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br J Pharmacol 109:3-5.
16. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994): Nomenclature classification of purinoceptors. Pharmacol Rev 46:143-156.
17. Galinanes M, Hearse DJ (1990): Assessment of ischemie injury protective interventions: The Langendorff versus the working rat heart preparation. Can J Cardiol 6:83-91.
18. 3 receptor-mediated hypotension in the rat. Br J Pharmacol 115:945-952.
19. 2 receptors in rat brain. J Pharmacol Exp Ther 251:888-893.
20. Kogi K, Uchibori T, Aihara K, Yamaguchi T, Abiru T (1991): Pharmacological profile of the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146) in the cardiovascular system. Jpn J Pharmacol 57:153-165.
21. 2 agonist produces both direct and reflex tachycardia in normotensive rats. J Cardiovasc Pharmacol 19:460-463.
22. Lasley RD, Bunger R, Metzer RM (1995): Receptor mediated metabolic effects of adenosine in ischemie post-ischemie myocardium. In Belardinelli L, Pelleg R (eds): Adenosine Adenine Nueleotides: From Molecular Biology to Physiology. Boston: Kluwer Academic Publishers, pp 351-360.
23. 2 receptor. J Pharmacol Exp Ther 257:1005-1012.
24. 2A receptor agonists in the isolated rat heart. J Cardiovasc Pharmacol (in press).
25. 1 selective adenosine agonist, RG14202. J Pharmacol Exp Ther 265:699-706.
26. Merkel LA, Hawkins ED, Colussi DJ, Greenland BD, Smits GJ, Perrone MH, Cox BF (1995): Cardiovascular and antilipolytic effects of the adenosine agonist GR 79236. Pharmacology 51: 224-236.
27. Moser GH, Schrade J, Deussen A (1989): Turnover of adenosine in plasma of human dog blood. Am J Physiol 256:C799-C806.
28. Mullane KM, Williams M (1990): Adenosine and cardiovascular function. In Williams M (ed): Adenosine and Adenosine Receptors. Clifton, NJ: Humana Press, pp 289-333.
29. Munson PJ, Rodbard P (1980): LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
30. 2-receptor agonists on myocardial reperfusion injury. Am Heart J 123:332-338.
31. Ohnishi A, Biaggioni I, Deray G, Branch RA, Jackson EK (1986): Hemodynamic effects of adenosine in conscious hypertensive normotensive rats. Hypertension 8:391-398.
32. Olah ME, Stiles GL (1995): Adenosine receptor subtypes: Characterization therapeutic regulation. Annu Rev Pharmacol Toxicol 35:581-606.
33. Olsson RA, Pearson JD (1990): Cardiovascular purinoceptors. Physiol Rev 70:761-845.
34. Sala C, Monopoli A, Alberti C, Casati C, Ongini E, Zanchetti A, Morganti A (1996): Humoral effects of selective adenosine agonists in spontaneously hypertensive rats. J Hypertens 14:75-79.
35. Salomon Y (1979): Adenylate cyclase assay. In Brooker C, Greengard P, Robison GA (eds): Advances in Cyclic Nucleotide Research. New York: Raven Press, Vol 10, pp 35-53.
36. SAS Institute, Inc. (1989): SAS/STAT Guide for Personal Computers. Version 6. Gary, NC: SAS Institute, Inc.
37. 2 receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J Cardiovasc Pharmacol 22:89-96.
38. Wagner H, Milavec-Krizman M, Gadient F, Menninger K, Schoeffter P, Tapparelli C, Pfannkuche HJ, Fozard JR (1995): General pharmacology of SDZ WAG 994, a potent selective orally active adenosine A, receptor agonist. Drug Dev Res 34:276-288.
39. Webb RL, McNeal RB Jr, Barclay BW, Yasay GD (1990): Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 254:1090-1099.